Skip to main content

Advertisement

SpringerLink
Log in

Relationship Between Serum Cytokine Profile and Circulating Neutrophils Phenotype in Patients with Benign Ovarian Tumors and Ovarian Cancer

  • Published:
BioNanoScience Aims and scope Submit manuscript

Abstract

Changes in the cytokine microenvironment determine the anti- (N1) and pro-tumor (N2) activity of neutrophils (Nph), which has been shown in multiple in vitro studies. We aimed to evaluate the relationship between serum cytokine profile and circulating Nph phenotype in patients with benign ovarian tumors (BOT) and ovarian cancer (OC). The study included patients with BOT (n = 15), primary stage I–IV OC patients before treatment (n = 63), and healthy donors (n = 22) as a control group. The levels of cytokines were estimated in Nph and blood serum; NF-kBp65 was assessed in the Nph nuclear fraction. The myeloperoxidase (MPO) activity, the ability to generate ROS (spontaneous NBT test), and phagocytosis were assessed in Nph by the cytochemical method. The CD11b+, CD16+, CD64+, CD95+ Nph counts, the neutrophil traps (NETs) generation were assessed by fluorescence microscopy. Atomic force microscopy was used to determine Nph membrane stiffness. Statistical analysis was performed using Statistica 13 (TIBCO, USA). We observed N1 and N2 subpopulations of Nph in patients with BOT and OC, considering the surface markers, cytokine/growth factors expression, and effector functions. Multiple and simple linear regression models allowed us to propose the combinations of serum cytokines which could polarize circulating Nph into pro- and anti-tumor populations, including the cytokines involved in the NF-kB-signaling. According to the logistic regression, analysis could differentiate between OC and BOT. The assessment of circulating N1 and N2 populations may be advantageous to identify the tumor-promoting neutrophil markers and contribute to the development of therapeutic strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Arnold M, Rutherford MJ, Bardot A, et al (2019) Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): A population-based study. Lancet Oncol 20:1493–1505. https://pubmed.ncbi.nlm.nih.gov/31521509/

  2. Aloe C, Wang H, Vlahos R, Irving L, Steinfort D, Bozinovski S (2021) Emerging and multifaceted role of neutrophils in lung cancer. Transl Lung Cancer Res 10:2806–2818. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264329/

  3. Antonio N, Bønnelykke‐Behrndtz ML, Ward LC, Collin J, Christensen IJ, Steiniche T, Schmidt H, Feng Y, Martin P (2015) The wound inflammatory response exacerbates growth of pre‐neoplastic cells and progression to cancer. EMBO J 34:2219–2236. https://pubmed.ncbi.nlm.nih.gov/26136213/

  4. Wang J (2018) Neutrophils in tissue injury and repair. Cell Tissue Res 371:531–539. https://pubmed.ncbi.nlm.nih.gov/29383445/

  5. Granot Z (2019) Neutrophils as a therapeutic target in cancer. Front Immunol 10:1710. https://pubmed.ncbi.nlm.nih.gov/31379884/

  6. Templeton, A. J., McNamara, M. G., Šeruga, B., et al. (2014). Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: A systematic review and meta-analysis. JNCI J Natl Cancer Inst. https://doi.org/10.1093/jnci/dju124

    Article  Google Scholar 

  7. Maria de Souza C, Fonseca de Carvalho L, da Silva Vieira T, Cândida Araújo e Silva A, Teresa Paz Lopes M, Alves Neves Diniz Ferreira M, Passos Andrade S, Dantas Cassali G (2012) Thalidomide attenuates mammary cancer associated-inflammation, angiogenesis and tumor growth in mice. Biomed Pharmacother 66:491–498. https://europepmc.org/article/med/22705333

  8. Lerman I, Hammes SR (2018) Neutrophil elastase in the tumor microenvironment. Steroids 133:96–101. https://pubmed.ncbi.nlm.nih.gov/29155217/

  9. Wang X, Qiu L, Li Z, Wang X-Y, Yi H (2018) Understanding the multifaceted role of neutrophils in cancer and autoimmune diseases. Front Immunol 9:2456. https://www.frontiersin.org/articles/https://doi.org/10.3389/fimmu.2018.02456/full

  10. Ohms M, Möller S, Laskay T (2020) An attempt to polarize human neutrophils toward N1 and N2 phenotypes in vitro. Front Immunol 11:532. https://www.frontiersin.org/articles/https://doi.org/10.3389/fimmu.2020.00532/full

  11. Faul F., Erdfelder E., Lang A.-G., Buchner A (2007) G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 39: 175–191. https://pubmed.ncbi.nlm.nih.gov/17695343/

  12. Nesterova I, Shvydchenko I, Romenskaja V, Fomicheva E, Sin’kov S (2010) Method of predicting the development of generalised complications in case of acute destructive pancreaTITIS. https://rusneb.ru/catalog/000224_000128_0002393771_20100710_C1_RU/

  13. Dolgushin I, Andreeva J (2010) Method for detecting neutrophilic traps. http://www.freepatent.ru/patents/2384844

  14. Kampan NC, Madondo MT, Reynolds J, Hallo J, McNally OM, Jobling TW, Stephens AN, Quinn MA, Plebanski M (2020) Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer. Sci Rep 10:2213. https://pubmed.ncbi.nlm.nih.gov/32042020/

  15. Mouchemore KA, Anderson RL, Hamilton JA (2018) Neutrophils, G-CSF and their contribution to breast cancer metastasis. FEBS J 285:665–679. https://pubmed.ncbi.nlm.nih.gov/28834401/

  16. Bushnell GG, Rao SS, Hartfield RM, Zhang Y, Oakes RS, Jeruss JS, Shea LD (2020) Microporous scaffolds loaded with immunomodulatory lentivirus to study the contribution of immune cell populations to tumor cell recruitment in vivo. Biotechnol Bioeng 117:210–222. https://pubmed.ncbi.nlm.nih.gov/31544959/

  17. Zhang X, Shi H, Yuan X, Jiang P, Qian H, Xu W (2018) Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration. Mol Cancer 17:146. https://molecular-cancer.biomedcentral.com/articles/https://doi.org/10.1186/s12943-018-0898-6

  18. Wang X, Luo F, Zhao H (2014) Paraquat-induced reactive oxygen species inhibit neutrophil apoptosis via a p38 MAPK/NF-κB–IL-6/TNF-α positive-feedback circuit. PLoS ONE 9:e93837. https://journals.plos.org/plosone/article?id=https://doi.org/10.1371/journal.pone.0093837

  19. Martire-Greco D, Rodriguez-Rodrigues N, Landoni VI, Rearte B, Isturiz MA, Fernández GC (2013) Interleukin-10 controls human peripheral PMN activation triggered by lipopolysaccharide. Cytokine 62:426–432. https://pubmed.ncbi.nlm.nih.gov/23602200/

  20. Lee W, Ko SY, Mohamed MS, Kenny HA, Lengyel E, Naora H (2019) Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum. J Exp Med 216:176–194. https://pubmed.ncbi.nlm.nih.gov/30567719/

  21. Coughlan AM, Freeley SJ, Robson MG (2012) Humanised mice have functional human neutrophils. J Immunol Methods 385:96–104. https://pubmed.ncbi.nlm.nih.gov/22917930/

  22. Teijeira A, Garasa S, Ochoa MC, et al (2021) IL8, Neutrophils, and NETs in a collusion against cancer immunity and immunotherapy. Clin Cancer Res 27:2383–2393. https://pubmed.ncbi.nlm.nih.gov/33376096/

  23. Gandhi KA, Goda JS, Gandhi VV, et al (2019) Oral administration of 3,3′-diselenodipropionic acid prevents thoracic radiation induced pneumonitis in mice by suppressing NF-kB/IL-17/G-CSF/neutrophil axis. Free Radic Biol Med 145:8–19. https://pubmed.ncbi.nlm.nih.gov/31521664/

  24. Bashant KR, Vassallo A, Herold C, et al (2019) Real-time deformability cytometry reveals sequential contraction and expansion during neutrophil priming. J Leukoc Biol 105:1143–1153. https://pubmed.ncbi.nlm.nih.gov/30835869/

  25. McClenahan DJ, Evanson OA, Walcheck BK, Weiss DJ (2000) Association among filamentous actin content, CD11b expression, and membrane deformability in stimulated and unstimulated bovine neutrophils. Am J Vet Res 61:380–386. https://pubmed.ncbi.nlm.nih.gov/10772101/

  26. Skoutelis AT, Kaleridis VE, Goumenos DS, Athanassiou GM, Missirlis YF, Vlachojannis JG, Bassaris HP (2000) Polymorphonuclear leukocyte rigidity is defective in patients with chronic renal failure. Nephrol Dial Transplant 15:1788–1793. https://pubmed.ncbi.nlm.nih.gov/11071966/

  27. Andzinski L, Kasnitz N, Stahnke S, Wu C-F, Gereke M, von Köckritz-Blickwede M, Schilling B, Brandau S, Weiss S, Jablonska J (2016) Type IIFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human: TANs in tumorigenesis. Int J Cancer 138:1982–1993. https://pubmed.ncbi.nlm.nih.gov/26619320/

  28. Spiegel A, Brooks MW, Houshyar S, et al (2016) Neutrophils suppress intraluminal NK cell–mediated tumor cell clearance and enhance extravasation of disseminated carcinoma cells. Cancer Discov 6:630–649. https://pubmed.ncbi.nlm.nih.gov/27072748/

  29. Giese MA, Hind LE, Huttenlocher A (2019) Neutrophil plasticity in the tumor microenvironment. Blood 133:2159–2167. https://pubmed.ncbi.nlm.nih.gov/30898857/

  30. Sun R, Luo J, Li D, Shu Y, Luo C, Wang S-S, Qin J, Zhang G-M, Feng Z-H (2014) Neutrophils with protumor potential could efficiently suppress tumor growth after cytokine priming and in presence of normal NK cells. Oncotarget 5:12621–12634. https://www.oncotarget.com/article/2181/text/

  31. Bekes EM, Schweighofer B, Kupriyanova TA, Zajac E, Ardi VC, Quigley JP, Deryugina EI (2011) Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. Am J Pathol 179:1455–1470. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157227/

  32. Tay SH, Celhar T, Fairhurst A (2020) Low‐density neutrophils in systemic lupus erythematosus. Arthritis Rheumatol 72:1587–1595. https://onlinelibrary.wiley.com/doi/full/https://doi.org/10.1002/art.41395

  33. Eruslanov EB, Bhojnagarwala PS, Quatromoni JG, et al (2014) Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest 124:5466–5480. https://pubmed.ncbi.nlm.nih.gov/25384214/

  34. Masucci MT, Minopoli M, Carriero MV (2019) Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy. Front Oncol 9:1146. https://www.frontiersin.org/articles/https://doi.org/10.3389/fonc.2019.01146/full

  35. Dumitru CA, Lang S, Brandau S (2013) Modulation of neutrophil granulocytes in the tumor microenvironment: Mechanisms and consequences for tumor progression. Semin Cancer Biol 23:141–148. https://pubmed.ncbi.nlm.nih.gov/23485549/

  36. Lin C, Lin W, Yeh S, Li L, Chang C (2015) Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signals. Oncotarget 6:43081–43089. https://www.oncotarget.com/article/5638/text/

  37. Egholm C, Heeb LEM, Impellizzieri D, Boyman O (2019) The regulatory effects of interleukin-4 receptor signaling on neutrophils in type 2 immune responses. Front Immunol 10:2507. https://www.frontiersin.org/articles/https://doi.org/10.3389/fimmu.2019.02507/full

  38. Zhu T, Zou X, Yang C, Li L, Wang B, Li R, Li H, Xu Z, Huang D, Wu Q (2021) Neutrophil extracellular traps promote gastric cancer metastasis by inducing epithelial‑mesenchymal transition. Int J Mol Med 48:127. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128417/

  39. Zhu EF, Gai SA, Opel CF, et al (2015) Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2. Cancer Cell 27:489–501. https://pubmed.ncbi.nlm.nih.gov/25873172/

  40. Valle-Mendiola A, Gutiérrez-Hoya A, Lagunas-Cruz M del C, Weiss-Steider B, Soto-Cruz I (2016) Pleiotropic effects of IL-2 on cancer: Its role in cervical cancer. Mediators Inflamm 2016:1–11. https://pubmed.ncbi.nlm.nih.gov/27293315/

  41. Kang I, Wang Q, Eppell SJ, Marchant RE, Doerschuk CM (2010) Effect of neutrophil adhesion on the mechanical properties of lung microvascular endothelial cells. Am J Respir Cell Mol Biol 43:591–598. https://pubmed.ncbi.nlm.nih.gov/20023207/

  42. Ma X, Aoki T, Tsuruyama T, Narumiya S (2015) Definition of prostaglandin E 2 –EP2 signals in the colon tumor microenvironment that amplify inflammation and tumor growth. Cancer Res 75:2822–2832. https://pubmed.ncbi.nlm.nih.gov/26018088/

  43. Kaneda MM, Messer KS, Ralainirina N, et al (2016) PI3Kγ is a molecular switch that controls immune suppression. Nature 539:437–442. https://pubmed.ncbi.nlm.nih.gov/27642729/

  44. Braza MS, Conde P, Garcia M, et al (2018) Neutrophil derived CSF1 induces macrophage polarization and promotes transplantation tolerance. Am J Transplant 18:1247–1255. https://pubmed.ncbi.nlm.nih.gov/29314558/

  45. Mihaila AC, Ciortan L, Macarie RD, Vadana M, Cecoltan S, Preda MB, Hudita A, Gan AM, Jakobsson G, Tucureanu MM, Barbu E, Balanescu S, Simionescu M, Schiopu A, Butoi E. (2021) Transcriptional profiling and functional analysis of N1/N2 neutrophils reveal an immunomodulatory effect of S100A9-blockade on the pro-inflammatory N1 subpopulation.. Front Immunol 12:708770. https:// pubmed.ncbi.nlm.nih.gov/34447377/

  46. Li S, Cong X, Gao H, et al (2019) Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells. J Exp Clin Cancer Res 38:6. https://pubmed.ncbi.nlm.nih.gov/30616627/

  47. Mishalian I, Bayuh R, Eruslanov E, Michaeli J, Levy L, Zolotarov L, Singhal S, Albelda SM, Granot Z, Fridlender ZG (2014) Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17-A new mechanism of impaired antitumor immunity: Neutrophils recruit regulatory T-cells into tumors via CCL17. Int J Cancer 135:1178–1186. https://pubmed.ncbi.nlm.nih.gov/24501019/

  48. Moreno SE, Alves-Filho JC, Bertozi G, Alfaya TM, Thèze J, Ferreira SH, Vargaftig BB (2006) Systemic administration of interleukin-2 inhibits inflammatory neutrophil migration: role of nitric oxide: IL-2 and inhibition of neutrophil migration. Br J Pharmacol 148:1060–1066. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1752014/

  49. Chen C-L, Wang Y, Huang C-Y, et al (2018) IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma. OncoImmunology 7:e1373234. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739574/

  50. Raghavan S, Mehta P, Xie Y, Lei YL, Mehta G (2019) Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments. J Immunother Cancer 7:190. https://pubmed.ncbi.nlm.nih.gov/31324218/

  51. Weng Y-S, Tseng H-Y, Chen Y-A, Shen P-C, Al Haq AT, Chen L-M, Tung Y-C, Hsu H-L (2019) MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer. Mol Cancer 18:42. https://molecular-cancer.biomedcentral.com/articles/https://doi.org/10.1186/s12943-019-0988-0

Download references

Author information

Authors and Affiliations

  1. FSBI HE Ulyanovsk State University, Ulyanovsk, Russia

    Tatyana V. Abakumova, Snezhanna O. Gening & Tatyana P. Gening

Authors
  1. Tatyana V. Abakumova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Snezhanna O. Gening
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tatyana P. Gening
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceived the study and designed the experiment—T.V. Abakumova, T.P. Gening. Collected the data and performed the analysis—T.V. Abakumova, S.O. Gening. Wrote the paper—T.V. Abakumova, T.P. Gening, S.O. Gening. Edited the manuscript—T.V. Abakumova, T.P. Gening, S.O. Gening.

The study was approved by the ethics committee of the Institute of Medicine, Ecology and Physical Education of Ulyanovsk State University (Protocol No. 1 from 15/01/2011).

Corresponding author

Correspondence to Tatyana V. Abakumova.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abakumova, T.V., Gening, S.O. & Gening, T.P. Relationship Between Serum Cytokine Profile and Circulating Neutrophils Phenotype in Patients with Benign Ovarian Tumors and Ovarian Cancer. BioNanoSci. 12, 708–722 (2022). https://doi.org/10.1007/s12668-022-00974-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12668-022-00974-2

Keywords

Search

Navigation